Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-05 @ 5:52 PM
Study NCT ID:
NCT01897532
Status:
COMPLETED
Last Update Posted:
2019-04-04
First Post:
2013-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-09
First Submit QC Date:
None
Study First Post Date:
2013-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-21
Results First Submit QC Date:
None
Results First Post Date:
2019-01-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-21
Last Update Post Date:
2019-04-04
Last Update Post Date Type:
ACTUAL